The project

The aim is to design and industrialize new pharmacological in vitro assays for the screening of compounds/biopharmaceuticals in 3D, combining microfluidics, BioMEMS systems and BIOMIMESYS®. The idea is to allow the development of more complex and relevant cellular structures for predictive therapeutical screens (e.g. reconstitution of a tumor and its vascularization for anti-cancer drugs), in a format allowing a higher throughput than existing systems.

What we bring to the partnership

These devices will include our 3D cell culture hydroscaffold™ BIOMIMESYS®, as a biomimetic material for mimicking the extracellular matrix.

List of partners

List of related articles